UK Insulin Drugs And Delivery Devices Market Share

Statistics for the 2023 & 2024 UK Insulin Drugs And Delivery Devices market share, created by Mordor Intelligence™ Industry Reports. UK Insulin Drugs And Delivery Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Device Drug Combination Research Diagnostics and Therapeutics Research Diabetes Care Research Insulin Drugs & Delivery Devices Market in UK Market Share

Market Share of UK Insulin Drugs And Delivery Devices Industry

The United Kingdom Insulin Drugs and Delivery Devices Market is consolidated, with few significant and generic players. Mergers and acquisitions that happened between the players in the recent past have helped the companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim together have an alliance in developing and commercializing Basaglar (Insulin Glargine). Additionally, the players in the recent past helped the companies strengthen their market presence; for example, Novo Nordisk collaborated with Ypsomed to provide better insulin therapy solutions.

UK Insulin Drugs & Delivery Devices Market Leaders

  1. Eli Lilly

  2. Sanofi

  3. Novo Nordisk

  4. Medtronic

  5. Ypsomed

*Disclaimer: Major Players sorted in no particular order

UK Insulin Drugs And Delivery Devices Market Concentration

UK Insulin Drugs & Delivery Devices Market Report Snapshots

UK Insulin Drugs & Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)